{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:16:14Z","timestamp":1783142174886,"version":"3.54.6"},"reference-count":18,"publisher":"Japanese Society of Veterinary Science","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1292\/jvms.25-0551","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:09:30Z","timestamp":1776895770000},"page":"951-955","source":"Crossref","is-referenced-by-count":0,"title":["Progress and prospects in HIV\/AIDS pathogenicity research using rhesus macaque models: from SHIV model development to neutralizing antibody induction"],"prefix":"10.1292","volume":"88","author":[{"given":"Hiromi","family":"SAKAWAKI","sequence":"first","affiliation":[{"name":"Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"MIURA","sequence":"additional","affiliation":[{"name":"Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med<\/i> 200: 749\u2013759.","DOI":"10.1084\/jem.20040874"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fukazawa Y, Miyake A, Ibuki K, Inaba K, Saito N, Motohara M, et al. 2008. Small intestine CD4+ T-cells are profoundly depleted during acute infection of simian-human immunodeficiency virus regardless of its pathogenicity. J Virol<\/i> 82: 6039\u20136044.","DOI":"10.1128\/JVI.02753-07"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Haim H, Salas I, Sodroski J. 2013. Proteolytic processing of the human immunodeficiency virus envelope glycoprotein precursor decreases conformational flexibility. J Virol<\/i> 87: 1884\u20131889.","DOI":"10.1128\/JVI.02765-12"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Himeno A, Ishida Y, Mori H, Matsuura K, Kikukawa M, Sakawaki H, Miura T. 2019. Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian\/human immunodeficiency virus. Arch Virol<\/i> 164: 1297\u20131308.","DOI":"10.1007\/s00705-019-04173-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Inaba K, Fukazawa Y, Matsuda K, Himeno A, Matsuyama M, Ibuki K, Miura Y, Koyanagi Y, Nakajima A, Blumberg RS, Takahashi H, Hayami M, Igarashi T, Miura T. 2010. Small intestine CD4+ cell reduction and enteropathy in SHIV-KS661-infected rhesus macaques in presence of low viral load. J Gen Virol<\/i> 91: 773\u2013781.","DOI":"10.1099\/vir.0.017368-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ishida Y, Yoneda M, Otsuki H, Watanabe Y, Kato F, Matsuura K, Kikukawa M, Matsushita S, Hishiki T, Igarashi T, Miura T. 2016. Generation of a neutralization-resistant CCR5 tropic SHIV-MK38 molecular clone, a derivative of SHIV-89.6. J Gen Virol<\/i> 97: 1249\u20131260.","DOI":"10.1099\/jgv.0.000421"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA<\/i> 105: 7552\u20137557.","DOI":"10.1073\/pnas.0802203105"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kozyrev IL, Ibuki K, Shimada T, Kuwata T, Takemura T, Hayami M, Miura T. 2001. Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus. Virology<\/i> 282: 6\u201313.","DOI":"10.1006\/viro.2000.0839"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Matsuda K, Inaba K, Fukazawa Y, Matsuyama M, Ibuki K, Horiike M, Saito N, Hayami M, Igarashi T, Miura T. 2010. In vivo<\/i> analysis of a new R5 tropic SHIV generated from the highly pathogenic SHIV-KS661, a derivative of SHIV-89.6. Virology<\/i> 399: 134\u2013143.","DOI":"10.1016\/j.virol.2010.01.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Matsuura K, Yamaura M, Sakawaki H, Himeno A, Pisil Y, Kobayakawa T, Tsuji K, Tamamura H, Matsushita S, Miura T. 2023. Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38C. Virology<\/i> 578: 171\u2013179.","DOI":"10.1016\/j.virol.2022.12.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moore PL, Gray ES, Wibmer CK, Bhiman JN, Nonyane M, Sheward DJ, Hermanus T, Bajimaya S, Tumba NL, Abrahams MR, Lambson BE, Ranchobe N, Ping L, Ngandu N, Abdool Karim Q, Abdool Karim SS, Swanstrom RI, Seaman MS, Williamson C, Morris L. 2012. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med<\/i> 18: 1688\u20131692.","DOI":"10.1038\/nm.2985"},{"key":"12","unstructured":"12. Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Donau OK, Buckler-White A, et al. 2010. Transfer of neutralizing IgG to macaques 6 hours after SHIV infection protects against AIDS. Nature<\/i> 465: 767\u2013771."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pancera M, Zhou T, Druz A, Georgiev IS, Soto C, Gorman J, Huang J, Acharya P, Chuang GY, Ofek G, Stewart-Jones GB, Stuckey J, Bailer RT, Joyce MG, Louder MK, Tumba N, Yang Y, Zhang B, Cohen MS, Haynes BF, Mascola JR, Morris L, Munro JB, Blanchard SC, Mothes W, Connors M, Kwong PD. 2014. Structure and immune recognition of trimeric pre-fusion HIV-1 Env<\/i>. Nature<\/i> 514: 455\u2013461.","DOI":"10.1038\/nature13808"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pisil Y, Yazici Z, Shida H, Matsushita S, Miura T. 2020. Specific substitutions in region V2 of gp120 env<\/i> confer SHIV neutralisation resistance. Pathogens<\/i> 9: 181.","DOI":"10.3390\/pathogens9030181"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR. 2010. Tiered categorization of a diverse panel of HIV-1 Env<\/i> pseudoviruses for assessment of neutralizing antibodies. J Virol<\/i> 84: 1439\u20131452.","DOI":"10.1128\/JVI.02108-09"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC, Lackner AA. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science<\/i> 280: 427\u2013431.","DOI":"10.1126\/science.280.5362.427"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW, Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DR. Protocol G Principal Investigators. 2009. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science<\/i> 326: 285\u2013289.","DOI":"10.1126\/science.1178746"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamaguchi-Kabata Y, Yamashita M, Ohkura S, Hayami M, Miura T. 2004. Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor. J Mol Evol<\/i> 58: 333\u2013340.","DOI":"10.1007\/s00239-003-2555-x"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/7\/88_25-0551\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:28:19Z","timestamp":1783139299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/7\/88_25-0551\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0551","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0551"}}